Ono Pharmaceutical , Ltd.'s current cash is $220B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), OPHLY shows a current cash of $220B. That compares with $140B in the prior-year period — up 56.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, OPHLY's current cash is now $220B (was $140B) — a 56.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ono Pharmaceutical , Ltd. is outperforming or lagging.
Tracking OPHLY's current cash over time shows whether Ono Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $220B That compares with $140B in the prior-year period — up 56.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Ono Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $220B) with ownership activity and broader fundamentals.